Summary
The search for DNA alterations that cause human disease has been an area of active research for more than 50 years, since the time that the genetic code was first solved. In the absence of data implicating chromosomal aberrations, researchers historically have performed whole genome linkage analysis or candidate gene association analysis to develop hypotheses about the genes that most likely cause a specific phenotype or disease. Whereas whole genome linkage analysis examines all chromosomal locations without a priori predictions regarding what genes underlie susceptibility, candidate gene association studies require a researcher to know in advance the genes that he or she wishes to test (based on their knowledge of a disease). To date, very few whole genome linkage studies and candidate gene studies have produced results that lead to generalizable findings about common diseases. One factor contributing to this lack of results has certainly been the previously limited resolution of the techniques. Recent technological advances, however, have made it possible to perform highly informative whole genome linkage and association analyses, as well as whole genome transcription (transcriptome) analysis. In addition, for the first time we can detect structural DNA aberrations throughout the genome on a fine scale. Each of these four approaches has its own strengths and weaknesses, but taken together, the results from an integrated analysis can implicate highly promising novel candidate genes. Here, we provide an overview of the integrated methodology that we have used to combine high-throughput genetic and functional genomic data with bioinformatics data that have produced new insights into the potential biological basis for schizophrenia. We believe that the potential of this combined approach is greater than that of a single mode of discovery, particularly for complex genetic diseases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Faraone, S.V., Glatt, S.J., and Taylor, L. (2004) The genetic basis of schizophrenia, in Early Clinical Intervention and Prevention in Schizophrenia, M.T. Tsuang, Editor. Humana Press: Totowa, New Jersey, pp. 3–25.
Kendler, K.S., Gruenberg, A.M., and Kinney, D.K. (1994) Independent diagnoses of adoptees and relatives as defined by DSM-III in the provincial and national samples of the Danish Adoption Study of Schizophrenia. Arch Gen Psychiatry 51(6):456–68.
Faraone, S.V., and Tsuang, M.T. (1985) Quantitative models of the genetic transmission of schizophrenia. Psychol Bull 98:41–66.
Gottesman, I.I., and Moldin, S.O. (1997) Schizophrenia genetics at the millennium: cautious optimism. Clin Genet 52(5):404–7.
Risch, N. (1990) Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46(2):222–8.
Lewis, C.M., Levinson, D.F., Wise, L.H., et al. (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73(1):34–48.
Singleton, A.B., Farrer, M., Johnson, J., et al. (2003) Alpha-synuclein locus triplication causes Parkinson’s disease. Science 302(5646):841.
Pulver, A.E., Nestadt, G., Goldberg, R., et al. (1994) Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 182(8):476–8.
Middleton, F.A., Trauzzi, M.G., Shrimpton, A.E., et al. (2006) Complete maternal uniparental isodisomy of chromosome 4 in a subject with major depressive disorder detected by high density SNP genotyping arrays. Am J Med Genet B Neuropsychiatr Genet 141(1):28–32.
Mirnics, K., Middleton, F.A., Marquez, A., Lewis, D.A., and Levitt, P. (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28(1):53–67.
Mirnics, K., Middleton, F.A., Lewis, D.A., and Levitt, P. (2001) Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 24(8):479–86.
Hakak, Y., Walker, J.R., Li, C., et al. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98(8):4746–51.
Bahn, S., Augood, S.J., Ryan, M., Standaert, D.G., Starkey, M., and Emson, P.C. (2001) Gene expression profiling in the post-mortem human brain – no cause for dismay. J Chem Neuroanat 22(1–2):79–94.
Vawter, M.P., Crook, J.M., Hyde, T.M., et al. (2002) Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 58(1):11–20.
Middleton, F.A., Mirnics, K., Pierri, J.N., Lewis, D.A., and Levitt, P. (2002) Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22(7):2718–29.
Middleton, F.A., Peng, L., Lewis, D.A., Levitt, P., and Mirnics, K. (2005) Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia. Neuropsychopharmacology 30(5):974–83.
Tsuang, M.T., Nossova, N., Yager, T., et al. (2005) Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 133(1):1–5.
Middleton, F.A., Pato, C.N., Gentile, K.L., et al. (2005) Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet 136(1):12–25.
Pato, C.N., Azevedo, M.H., Pato, M.T., et al. (1997) Selection of homogeneous populations for genetic study: the Portugal genetics of psychosis project. Am J Med Genet 74(3):286–8.
Middleton, F.A., Pato, M.T., Gentile, K.L., et al. (2004) Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am J Hum Genet 74(5):886–97.
John, S., Shephard, N., Liu, G., et al. (2004) Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am J Hum Genet 75(1):54–64.
Schaid, D.J., Guenther, J.C., Christensen, G.B., et al. (2004) Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci. Am J Hum Genet 75(6):948–65.
Evans, D.M., and Cardon, L.R. (2004) Guidelines for genotyping in genomewide linkage studies: single-nucleotide-polymorphism maps versus microsatellite maps. Am J Hum Genet 75(4):687–92.
Abecasis, G.R., Cherny, S.S., Cookson, W.O., and Cardon, L.R. (2002) Merlin – rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30(1):97–101.
Petryshen, T.L., Middleton, F.A., Kirby, A., et al. (2005) Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 10(4):328, 366–74.
Petryshen, T.L., Middleton, F.A., Tahl, A.R., et al. (2005) Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry 10(12):1057, 1074–88.
Dracheva, S., Elhakem, S.L., McGurk, S.R., Davis, K.L., and Haroutunian, V. (2004) GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res 76(4):581–92.
Heldt, S.A., Green, A., and Ressler, K.J. (2004) Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychopharmacology 29(9):1610–9.
Lewis, D.A., Hashimoto, T., and Volk, D.W. (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6(4):312–24.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Middleton, F., Rosenow, C., Vailaya, A., Kuchinsky, A., Pato, M., Pato, C. (2007). Integrating Genetic, Functional Genomic, and Bioinformatics Data in a Systems Biology Approach to Complex Diseases: Application to Schizophrenia. In: Neuroinformatics. Methods in Molecular Biology™, vol 401. Humana Press. https://doi.org/10.1007/978-1-59745-520-6_18
Download citation
DOI: https://doi.org/10.1007/978-1-59745-520-6_18
Publisher Name: Humana Press
Print ISBN: 978-1-58829-720-4
Online ISBN: 978-1-59745-520-6
eBook Packages: Springer Protocols